Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.21% |
| 2 | Healthcare | 10.45% |
| 3 | Technology | 8.65% |
| 4 | Financials | 8.6% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
| $1.21M | ﹤0.01% |
20,848
-416,781
| -95% | -$23.1M |
|
2877
PUT
Plains All American Pipeline
PAA
$18B
| $1.21M | ﹤0.01% |
+66,000
| New | +$1.21M |
|
2878
Globant
GLOB
$1.73B
| $1.21M | ﹤0.01% |
11,438
-26,286
| -70% | -$2.62M |
|
2879
Alpha Metallurgical Resources
AMR
$2.88B
| $1.21M | ﹤0.01% |
+133,833
| New | +$2.04M |
|
|
SILK
2880
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.21M | ﹤0.01% |
+30,000
| New | +$1.05M |
|
2881
PUT
Humana
HUM
$47.1B
| $1.21M | ﹤0.01% |
3,300
-200
| -6% | -$63.4K |
|
2882
Xeris Biopharma Holdings
XERS
$1.57B
| $1.21M | ﹤0.01% |
171,460
+77,982
| +83% | +$644K |
|
2883
HUTCHMED
HCM
$2.16B
| $1.21M | ﹤0.01% |
48,093
+19,856
| +70% | +$435K |
|
|
ETRN
2884
CALL
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $1.2M | ﹤0.01% |
90,000
| – | – |
|
|
OTIC
2885
DELISTED
Otonomy, Inc.
OTIC
| $1.2M | ﹤0.01% |
313,868
+295,753
| +1,633% | +$722K |
|
2886
Danaos Corp
DAC
$2.75B
| $1.2M | ﹤0.01% |
+130,790
| New | +$1.26M |
|
2887
Emergent Biosolutions
EBS
$305M
| $1.2M | ﹤0.01% |
22,261
-352,248
| -94% | -$19.1M |
|
2888
Cato Corp
CATO
$53.1M
| $1.2M | ﹤0.01% |
68,964
-81,919
| -54% | -$1.47M |
|
|
NBL
2889
DELISTED
Noble Energy, Inc.
NBL
| $1.2M | ﹤0.01% |
48,266
-8,530,392
| -99% | -$181M |
|
|
HARP
2890
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.2M | ﹤0.01% |
+8,102
| New | +$1.23M |
|
|
GREK
2891
Global X MSCI Greece ETF
GREK
$344M
| $1.2M | ﹤0.01% |
+39,318
| New | +$1.15M |
|
2892
Varex Imaging
VREX
$779M
| $1.19M | ﹤0.01% |
40,028
-7,197
| -15% | -$215K |
|
|
TSC
2893
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.19M | ﹤0.01% |
+45,655
| New | +$1.09M |
|
|
USCR
2894
DELISTED
U S Concrete, Inc.
USCR
| $1.19M | ﹤0.01% |
28,601
-17,267
| -38% | -$790K |
|
2895
PUT
PG&E
PCG
$39.5B
| $1.19M | ﹤0.01% |
+109,500
| New | +$938K |
|
2896
Oxford Square Capital
OXSQ
$146M
| $1.19M | ﹤0.01% |
218,411
+201,644
| +1,203% | +$1.11M |
|
2897
CALL
Williams Companies
WMB
$90.7B
| $1.19M | ﹤0.01% |
50,000
+40,000
| +400% | +$916K |
|
2898
CALL
AnaptysBio
ANAB
$1.7B
| $1.19M | ﹤0.01% |
72,900
-390,000
| -84% | -$9.22M |
|
2899
CALL
Elanco Animal Health
ELAN
$12.2B
| $1.18M | ﹤0.01% |
+40,000
| New | +$1.09M |
|
2900
PUT
Globus Medical
GMED
$11.1B
| $1.18M | ﹤0.01% |
+20,000
| New | +$1.09M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $4.28B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.